Listed

Genenta Science S.p.A.

GNTANasdaqCIK 1838716Healthcare

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Balance sheet

Cash and equivalentsEUR 4.0k, FY2024
Shareholders' equityEUR 21.8m, FY2025
Line itemUnitperiod not labelled2018-12-31period not labelled2019-12-31period not labelled2020-12-31FY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31
Cash and equivalents$mnot reportednot reported0.0Cash and equivalents, period not labelled, at 2020-12-31EUR 2.4k. XBRL concept us-gaap:Cash. 20-F filed 2022-05-02, accession 0001493152-22-011671.Report this figure25.7Cash and equivalents, FY2021, at 2021-12-31$25.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 20-F filed 2022-05-02, accession 0001493152-22-011671.Report this figure0.0Cash and equivalents, FY2022, at 2022-12-31EUR 4.0k. XBRL concept us-gaap:Cash. 20-F filed 2025-03-28, accession 0001641172-25-001207.Report this figure0.0Cash and equivalents, FY2023, at 2023-12-31EUR 4.0k. XBRL concept us-gaap:Cash. 20-F filed 2026-04-01, accession 0001493152-26-014387.Report this figure0.0Cash and equivalents, FY2024, at 2024-12-31EUR 4.0k. XBRL concept us-gaap:Cash. 20-F filed 2026-04-01, accession 0001493152-26-014387.Report this figurenot reported
Current assets$mnot reportednot reported16.5Current assets, period not labelled, at 2020-12-31EUR 16.5m. XBRL concept us-gaap:AssetsCurrent. 20-F filed 2022-05-02, accession 0001493152-22-011671.Report this figure38.8Current assets, FY2021, at 2021-12-31EUR 38.8m. XBRL concept us-gaap:AssetsCurrent. 20-F filed 2024-03-29, accession 0001493152-24-011999.Report this figure31.7Current assets, FY2022, at 2022-12-31EUR 31.7m. XBRL concept us-gaap:AssetsCurrent. 20-F filed 2025-03-28, accession 0001641172-25-001207.Report this figure21.3Current assets, FY2023, at 2023-12-31EUR 21.3m. XBRL concept us-gaap:AssetsCurrent. 20-F filed 2026-04-01, accession 0001493152-26-014387.Report this figure14.5Current assets, FY2024, at 2024-12-31EUR 14.5m. XBRL concept us-gaap:AssetsCurrent. 20-F filed 2026-04-01, accession 0001493152-26-014387.Report this figure30.0Current assets, FY2025, at 2025-12-31EUR 30.0m. XBRL concept us-gaap:AssetsCurrent. 20-F filed 2026-04-01, accession 0001493152-26-014387.Report this figure
Total assets$mnot reportednot reported17.5Total assets, period not labelled, at 2020-12-31EUR 17.5m. XBRL concept us-gaap:Assets. 20-F filed 2022-05-02, accession 0001493152-22-011671.Report this figure40.0Total assets, FY2021, at 2021-12-31EUR 40.0m. XBRL concept us-gaap:Assets. 20-F filed 2024-03-29, accession 0001493152-24-011999.Report this figure33.4Total assets, FY2022, at 2022-12-31EUR 33.4m. XBRL concept us-gaap:Assets. 20-F filed 2025-03-28, accession 0001641172-25-001207.Report this figure22.3Total assets, FY2023, at 2023-12-31EUR 22.3m. XBRL concept us-gaap:Assets. 20-F filed 2026-04-01, accession 0001493152-26-014387.Report this figure14.8Total assets, FY2024, at 2024-12-31EUR 14.8m. XBRL concept us-gaap:Assets. 20-F filed 2026-04-01, accession 0001493152-26-014387.Report this figure31.9Total assets, FY2025, at 2025-12-31EUR 31.9m. XBRL concept us-gaap:Assets. 20-F filed 2026-04-01, accession 0001493152-26-014387.Report this figure
Current liabilities$mnot reportednot reported2.3Current liabilities, period not labelled, at 2020-12-31EUR 2.3m. XBRL concept us-gaap:LiabilitiesCurrent. 20-F filed 2022-05-02, accession 0001493152-22-011671.Report this figure1.1Current liabilities, FY2021, at 2021-12-31EUR 1.1m. XBRL concept us-gaap:LiabilitiesCurrent. 20-F filed 2024-03-29, accession 0001493152-24-011999.Report this figure2.2Current liabilities, FY2022, at 2022-12-31EUR 2.2m. XBRL concept us-gaap:LiabilitiesCurrent. 20-F filed 2025-03-28, accession 0001641172-25-001207.Report this figure1.7Current liabilities, FY2023, at 2023-12-31EUR 1.7m. XBRL concept us-gaap:LiabilitiesCurrent. 20-F filed 2026-04-01, accession 0001493152-26-014387.Report this figure2.1Current liabilities, FY2024, at 2024-12-31EUR 2.1m. XBRL concept us-gaap:LiabilitiesCurrent. 20-F filed 2026-04-01, accession 0001493152-26-014387.Report this figure2.1Current liabilities, FY2025, at 2025-12-31EUR 2.1m. XBRL concept us-gaap:LiabilitiesCurrent. 20-F filed 2026-04-01, accession 0001493152-26-014387.Report this figure
Shareholders' equity$m7.9Shareholders' equity, period not labelled, at 2018-12-31EUR 7.9m. XBRL concept us-gaap:StockholdersEquity. 20-F filed 2022-05-02, accession 0001493152-22-011671.Report this figure18.9Shareholders' equity, period not labelled, at 2019-12-31EUR 18.9m. XBRL concept us-gaap:StockholdersEquity. 20-F filed 2023-04-21, accession 0001493152-23-013272.Report this figure15.2Shareholders' equity, period not labelled, at 2020-12-31EUR 15.2m. XBRL concept us-gaap:StockholdersEquity. 20-F filed 2024-03-29, accession 0001493152-24-011999.Report this figure38.9Shareholders' equity, FY2021, at 2021-12-31EUR 38.9m. XBRL concept us-gaap:StockholdersEquity. 20-F filed 2025-03-28, accession 0001641172-25-001207.Report this figure31.1Shareholders' equity, FY2022, at 2022-12-31EUR 31.1m. XBRL concept us-gaap:StockholdersEquity. 20-F filed 2026-04-01, accession 0001493152-26-014387.Report this figure20.4Shareholders' equity, FY2023, at 2023-12-31EUR 20.4m. XBRL concept us-gaap:StockholdersEquity. 20-F filed 2026-04-01, accession 0001493152-26-014387.Report this figure12.5Shareholders' equity, FY2024, at 2024-12-31EUR 12.5m. XBRL concept us-gaap:StockholdersEquity. 20-F filed 2026-04-01, accession 0001493152-26-014387.Report this figure21.8Shareholders' equity, FY2025, at 2025-12-31EUR 21.8m. XBRL concept us-gaap:StockholdersEquity. 20-F filed 2026-04-01, accession 0001493152-26-014387.Report this figure

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. Listed shows no prices and gives no investment advice.